UDP-α-D-galactose disodium salt—the core active sugar supplier for glycobiology research and therapeutic development

UDP-α-D-galactose disodium salt is a crucial nucleotide sugar in the field of sugar science. As an activated galactose donor, it directly participates in various glycosylation processes in organisms. From basic scientific research to the development of cutting-edge therapies, it is a key tool molecule that reveals the mysteries of life and empowers biomedical innovation.

Chemical Information

· Chemical name: Uridine-5'-bisphosphate-α-D-galactose disodium salt

· English name: UDP-ALPHA-D-GALACTOSEDISODIUM SALT

· Chemical formula: C15H22N2Na2O17P2

· Molecular weight: 590.3g/mol

· CAS number: 137868-52-1

Structural features and functional core

The core value of UDP-α-D-galactose lies in its “activated” form:

· High-energy sugar donor: Unlike ordinary galactose, UDP-α-D-galactose provides the necessary energy for the glycosylation reaction through its terminal UDP (uridine diphosphate) group, allowing the addition of sugar chains to be carried out efficiently and specifically.

· Specific substrate for enzymatic reactions: As a natural substrate for a variety of glycosyltransferases, it can be specifically recognized and catalyzed to accurately transfer galactose residues to specific acceptors on proteins, lipids or other sugar chains.

· Excellent stability and solubility: The form of disodium salt gives the molecule excellent physical and chemical properties, especially high solubility and long-term storage stability in aqueous solution, which provides convenience for scientific research and industrial production.

Main applications and advantages

1. Key raw materials for the development of glycoprotein and antibody drugs

· Optimizing therapeutic proteins: Glycosylation is one of the most critical post-translational modifications of therapeutic antibodies and protein drugs, directly affecting their stability, half-life and biological activity. Using UDP-galactose as a substrate, the sugar chain structure of glycoproteins can be optimized through in vitro enzymatic reactions or cell engineering, thereby enhancing drug efficacy and reducing immunogenicity.

· Improve glycoprofiling analysis: In drug development and quality control, it is an essential reagent for analyzing and reconstructing the sugar chain structure of glycoproteins.

2. The cornerstone of the synthesis of blood group antigens and cell surface markers

· ABO blood group substance synthesis: UDP-galactose is the direct donor of galactose residues in B blood group antigen and AB blood group antigen, and is an important tool for studying blood group biology and transfusion medicine.

· Cell recognition and signaling: The biosynthesis of a large number of glycocalyx and glycoconjugates on the cell surface depends on UDP-galactose. It plays a central role in intercellular communication, immune response, and pathogen recognition.

3. Tools for cutting-edge disease research and diagnostic development

· Research on congenital glycosylation diseases: Certain diseases are related to abnormalities in glycosylation pathways, and UDP-galactose is a key molecule for studying the mechanisms of such diseases.

· Cancer biomarker exploration: Characteristic changes occur in the glycosylation pattern on the surface of tumor cells. UDP-galactose can be used to synthesize or detect these specific sugar structures, serving the development of new cancer diagnostic reagents and targeted therapies.

Conclusion

UDP-α-D-galactose disodium salt is not just a biochemical reagent, it is one of the writers of the "sugar code" that connects genetic codes and life functions. From designing the next generation of highly effective biopharmaceuticals, to deciphering the cellular language of cancer, to exploring the root causes of congenital diseases, its value is indispensable.